Applied Therapeutics, Inc. APLT

Set alert

Price alert · APLT

All alert types
0.10 USD 0.00 0.00%

At close · Jul 2

0.11 0.00 +2.04%

After hours · Jul 2, 4:00 PM ET

Bid
0.11 × 2
Ask
0.11 × 11
0.103 Day range 0.103
0.78 52-week range 10.62
YTD
+3.00%
1 year
-81.62%
Open
0.103
Prev close
0.103
Mkt cap
99.09M
Vol
0
Avg vol
5.16M
EPS
-1.42
P/E
0.00
Div yield
0.00%
More statistics
Low
0.103
High
0.103
Forward P/E
-1.85
Beta
2.02
Short ratio
3.25
Inst. own
103.35%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
6.47
200-d avg
5.81
1y target
5.92

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for APLT has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-27.42 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.1×
FY 2017: -20.0×FY 2018: -5.2×FY 2019: -7.7×FY 2020: -5.1×FY 2021: -2.2×FY 2022: -0.3×FY 2023: -2.4×FY 2024: -1.1×
FY 2017 5y median -2.2× FY 2024
P/S 263×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 28.2×FY 2024: 263×
FY 2017 5y median 0.0× FY 2024
P/B 2.1×
FY 2017: -21.7×FY 2018: 5.4×FY 2019: 10.7×FY 2020: 5.9×FY 2021: 3.7×FY 2022: 7.1×FY 2023: -16.5×FY 2024: 2.1×
FY 2017 5y median 3.7× FY 2024
P/FCF -1.4×
FY 2017: -27.0×FY 2018: -7.7×FY 2019: -9.6×FY 2020: -6.2×FY 2021: -2.5×FY 2022: -0.4×FY 2023: -5.1×FY 2024: -1.4×
FY 2017 5y median -2.5× FY 2024
EV/EBITDA -0.4×
FY 2017: 27618×FY 2018: -49.5×FY 2019: -7.3×FY 2020: -4.6×FY 2021: -1.7×FY 2022: -0.2×FY 2023: -2.0×FY 2024: -0.4×
FY 2017 5y median -1.7× FY 2024
EV/Sales 94.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 23.3×FY 2024: 94.2×
FY 2017 5y median 0.0× FY 2024
FCF Yield -70.6%
FY 2017: -3.7%FY 2018: -13.0%FY 2019: -10.4%FY 2020: -16.2%FY 2021: -39.6%FY 2022: -271.7%FY 2023: -19.5%FY 2024: -70.6%
FY 2017 5y median -39.6% FY 2024

Profitability

Gross Margin -10613.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -439.4%FY 2024: -10613.0%
FY 2017 5y median 0.0% FY 2024
Operating Margin -22922.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -645.8%FY 2024: -22922.9%
FY 2017 5y median 0.0% FY 2024
Net Margin -23214.1%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -1198.5%FY 2024: -23214.1%
FY 2017 5y median 0.0% FY 2024
ROE -185.3%
FY 2017: 108.1%FY 2018: -104.4%FY 2019: -139.6%FY 2020: -114.7%FY 2021: -168.8%FY 2022: -2031.7%FY 2023: 698.5%FY 2024: -185.3%
FY 2017 5y median -168.8% FY 2024
ROIC -174.4%
FY 2017: -186.9%FY 2018: -85.5%FY 2019: -131.6%FY 2020: -111.5%FY 2021: -163.3%FY 2022: -1373.8%FY 2023: 413.4%FY 2024: -174.4%
FY 2017 5y median -163.3% FY 2024
ROA -121.8%
FY 2017: -130.3%FY 2018: -81.6%FY 2019: -94.1%FY 2020: -89.9%FY 2021: -117.5%FY 2022: -215.1%FY 2023: -218.4%FY 2024: -121.8%
FY 2017 5y median -121.8% FY 2024

Growth (YoY)

Revenue -95.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -95.4%
FY 2017 FY 2024
Operating Income -61.6%
FY 2017: 0.0%FY 2018: -215.5%FY 2019: -237.2%FY 2020: -107.2%FY 2021: -11.8%FY 2022: 21.5%FY 2023: 22.2%FY 2024: -61.6%
FY 2017 FY 2024
EPS (diluted) 46.5%
FY 2017: 0.0%FY 2018: -283.0%FY 2019: -97.2%FY 2020: -20.6%FY 2021: 3.7%FY 2022: 47.1%FY 2023: 34.9%FY 2024: 46.5%
FY 2017 FY 2024
Free Cash Flow -52.8%
FY 2017: 0.0%FY 2018: -250.0%FY 2019: -224.7%FY 2020: -115.4%FY 2021: -16.0%FY 2022: 13.9%FY 2023: 29.3%FY 2024: -52.8%
FY 2017 FY 2024

Financial Health

Current Ratio 3.1×
FY 2017: 3.3×FY 2018: 4.6×FY 2019: 3.3×FY 2020: 4.8×FY 2021: 3.3×FY 2022: 1.1×FY 2023: 0.8×FY 2024: 3.1×
FY 2017 5y median 3.1× FY 2024
Quick Ratio 3.1×
FY 2017: 3.3×FY 2018: 4.6×FY 2019: 3.3×FY 2020: 4.8×FY 2021: 3.3×FY 2022: 1.1×FY 2023: 0.7×FY 2024: 3.1×
FY 2017 5y median 3.1× FY 2024
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.5×FY 2023: -0.0×FY 2024: 0.0×
FY 2017 5y median 0.0× FY 2024
Net Debt / EBITDA 0.7×
FY 2017: -1092×FY 2018: 13.8×FY 2019: 0.4×FY 2020: 0.6×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.4×FY 2024: 0.7×
FY 2017 5y median 0.5× FY 2024
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: -490×FY 2020: -169×FY 2021: -190×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2017 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2017 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31